---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-085213"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-17T07:38:05.292553+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# InMed to participate in H.C. Wainwright 27th Annual Global Investment Conference

## Summary
- Conference takes place September 8-10, 2025 in New York.
- Management will conduct one-on-one investor meetings and a corporate presentation is available online.
- COO Michael Woudenberg will highlight pipeline updates including INM-901 Alzheimer's program data from AAIC 2025.
- No new financial or operational results disclosed; presentation is for investor outreach.

## SEC filing metadata
- accession: 0001213900-25-085213
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390025085213/0001213900-25-085213-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390025085213/ea0256293-8k_inmed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-085213
- JSON: https://secwatch.observer/filing/0001213900-25-085213.json
- Plain text: https://secwatch.observer/filing/0001213900-25-085213.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.